Inovio Pharmaceuticals (INO) shares rallied 19% in the last trading session to close at $11.04. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 2.1% loss over the past four weeks.The sudden soaring of the stock price was observed after Inovio announced that its lead DNA medicine candidate, INO-3107, has received the Innovation Passport designation under the United Kingdom's Innovative Licensing and Access Pat ...